PIMREG and familial pancreatic carcinoma: Univariate and multivariate Cox analyses indicated the FAM64A mRNA expression may be a useful biomarker for pancreatic cancer prognosis, and ROC analysis confirmed the diagnostic value of FAM64A expression in pancreatic cancer.